• Colorectal disorders

Uceris Generic Name & Formulations

General Description

Budesonide 9mg; ext-rel tabs.

Pharmacological Class


How Supplied

Ext-rel tabs—30

Generic Availability


Uceris Indications


Induction of remission in patients with active, mild to moderate ulcerative colitis.

Uceris Dosage and Administration


Swallow whole. 9mg once daily in the AM for up to 8 weeks.


Not established.

Uceris Contraindications

Not Applicable

Uceris Boxed Warnings

Not Applicable

Uceris Warnings/Precautions


Active or quiescent tuberculosis, untreated fungal, bacterial, systemic viral or parasitic infections. Supplement with systemic glucocorticosteroid in surgery or other stress situations. Caution when transferring from steroids with high systemic availability (monitor). May unmask allergies previously controlled by systemic corticosteroids. If exposed to chickenpox or measles, consider immune globulin or antiviral prophylactic therapies. Hypertension. Diabetes. Osteoporosis. Peptic ulcer. Glaucoma. Cataracts. Moderate to severe liver disease: monitor for hypercorticism; consider discontinuing if occurs. Elderly. Pregnancy. Nursing mothers.

Uceris Pharmacokinetics

See Literature

Uceris Interactions


May be potentiated by CYP3A4 inhibitors (eg, ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, erythromycin); consider discontinuing. Avoid grapefruit or grapefruit juice. May be affected by gastric acid reducing agents (eg, PPIs, H2-blockers, antacids).

Uceris Adverse Reactions

Adverse Reactions

Headache, nausea, decreased blood cortisol, upper abdominal pain, fatigue, flatulence, abdominal distension, acne, urinary tract infection, arthralgia, constipation; hypercorticism, adrenal suppression, immunosuppression.

Uceris Clinical Trials

See Literature

Uceris Note

Not Applicable

Uceris Patient Counseling

See Literature